Europe Biopsy Devices Market, Size, Forecast 2022-2027

1
Europe Biopsy Devices Market
According to Renub Research, Europe Biopsy
Devices Market will reach US 996.3 Million in
2027. A biopsy is a medical operation that
removes tissues or cells from the organs to aid
in examining disorders. Surgeons, radiologists,
cardiologists, and other medical professionals
undertake the procedure using biopsy devices.
These devices are made to remove
diagnostic-quality specimens while minimizing
crush artifacts and tissue fragmentation. Biopsy
guiding systems, needle-based biopsy guns, biopsy
needles, and biopsy forceps are the most often
used biopsy instruments. They are being used in a
wide range of healthcare settings throughout
Europe, including medical clinics, diagnostic
facilities, and hospitals. Europe Biopsy Devices
Market Size is likely to expand at a CAGR of
6.90 during 2021 2027 Increased investments
in RD activities are driving the Europe Biopsy
Devices Market. For example, the European Union's
Horizon 2020 initiative awarded 6.3 million for
MRI research and liquid biopsy research.
Furthermore, increased public awareness regarding
biopsy procedures and screening tests contributes
to the region's market growth. Moreover,
healthcare professionals concentrate on minimally
invasive (MI) biopsy technologies, expected to
boost the market growth.
Europe Biopsy Devices Market
2
Europe Biopsy Devices Market
Europe Biopsy Devices Market 2021 2027
Europe Biopsy Devices Market
3
Europe Biopsy Devices Market
Needle-based Biopsy Instruments are Expected to
Hold a Major Market Share By Product,
needle-based biopsy has the largest market share
due to the rising demand for equipment for
obtaining samples from soft tissues of internal
organs such as the breasts, kidneys, and lungs.
Hence, the factor above is expected to contribute
to the overall market's growth during the
projected period. Furthermore, the growing demand
for Fine Aspiration Needles and Core Needles for
obtaining samples from soft tissues of internal
organs, including the breasts, prostate, and
lungs, is propelling the market forward. By
Imaging Technology, CT scan, Stereotactic Guided,
Ultrasound Guided, and MRI Guided are all
utilized extensively in treating breast cancer,
lung cancer, and prostate cancer across a wide
range of end-users, including diagnostic centers
and hospitals. Furthermore, enhanced healthcare
infrastructure and the rising occurrence of
infections have boosted the growth of biopsy
instruments over the forecast period. This is due
to the expansion of the healthcare sector in
emerging economies, increased out-of-pocket
healthcare spending, and the number of hospitals.
Europe Biopsy Devices Market
4
Europe Biopsy Devices Market
Regional Analysis Germany is the leading
contributor to the Europe Biopsy Devices
Industry In Europe, Germany is the top
contributor to the biopsy device market. It's
because of the high number of qualified medical
experts, well-developed infrastructure, and the
presence of the majority of essential
stakeholders. Furthermore, France is an
attractive site for medical device producers. The
rapid improvement of healthcare infrastructure in
emerging France, combined with high unmet patient
requirements and rising breast cancer incidence,
is expected to boost demand for biopsy
devices. Competitive Landscape The Biopsy
Devices Market in Europe is very competitive.
Becton, Dickinson and Company, Thermo Fisher
Scientific Inc, Bio-Rad Laboratories, Exact
Sciences (Genomic Health), Biocept, Biocartis,
Roche Diagnostics, Myriad Genetics Inc., Qiagen,
NeoGenomics Laboratories, and Quest Diagnostics
Inc. are the leading market competitors in the
biopsy devices industry.
Europe Biopsy Devices Market
5
Europe Biopsy Devices Market
To benefit the sector, these companies are
pursuing methods such as product introduction
through technological advancements and alliances.
New product launches are the most favored
strategy for market capitalization, followed by
collaborations and geographic expansion. How
COVID-19 Affected the Europe Biopsy Devices
Industry The Coronavirus outbreak damaged the
European biopsy diagnostics centers, hospitals,
supply chains, and clinical trials. Cancer
diagnoses were being delayed since diagnosis
services and screening programs had been halted
since the beginning of the COVID-19 outbreak.
Cancer patients had numerous obstacles outside of
the pandemic, including increased susceptibility
to severe infection and disruptions in treatment
or routine medical care. According to our
analysis, the Europe Biopsy Devices Market was
negatively impacted from the end of 2019 to the
beginning of 2020. According to our estimates,
Europe Biopsy Devices Market reached US 667.6
Billion in 2021 post recovery from the pandemic
scenario.
Request a free sample copy of the report
https//www.renub.com/request-sample-page.php?gtur
leurope-biopsy-devices-market-p.php
Europe Biopsy Devices Market
6
Europe Biopsy Devices Market
Renub Research latest report Europe Biopsy
Devices Market, Forecast By Product (Needle
Based, Biopsy Forceps, Localization Wire,
Others), Imaging Technology (CT scan,
Stereotactic Guided, Ultrasound Guided, MRI
Guided and Others), Country (United Kingdom,
France, Germany, Italy, Spain, Russia and Rest of
Europe), End-User (Diagnostic Centers, Hospitals
and Others), Application (Cancer Type) (Breast
Cancer, Lung Cancer, Prostate Cancer and Others),
Companies (Becton, Dickinson and Company, Thermo
Fisher Scientific Inc, Bio-Rad Laboratories,
Exact Sciences (Genomic Health), Biocept,
Biocartis, Roche Diagnostics, Myriad Genetics
Inc., Qiagen, NeoGenomics Laboratories, and Quest
Diagnostics Inc.) provides a detailed analysis
of Europe Biopsy Devices Industry.
Request a free Brochure copy of the report
https//www.renub.com/request-brochure-page.php?gt
urleurope-biopsy-devices-market-p.php
Europe Biopsy Devices Market
7
Europe Biopsy Devices Market
Forecast for Europe Biopsy Devices Market Share
() - by Countries (2022 - 2027)
Europe Biopsy Devices Market
8
Europe Biopsy Devices Market

• Product - The market has been studied from 4
  viewpoints
• Needle Based
• Biopsy Forceps
• Localization Wire
• Others
• Imaging Technology - The market has been studied
  from 5 viewpoints
• CT scan
• Stereotactic Guided
• Ultrasound Guided
• MRI Guided
• Others

Europe Biopsy Devices Market
9
Europe Biopsy Devices Market
Country - The market has been studied from 7
viewpoints United Kingdom France
Germany Italy Spain Russia Rest of
Europe End-User - The market has been studied
from 3 viewpoints Diagnostic Centers Hospitals O
thers
Europe Biopsy Devices Market
10
Europe Biopsy Devices Market

• Application (Cancer Type) - The market has been
  studied from 4 viewpoints
• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Others
• Company Insights
• Overview
• Initiatives/Recent Developments
• Financial Insight

Europe Biopsy Devices Market
11
Europe Biopsy Devices Market

• Companies Covered
• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc
• Bio-Rad Laboratories
• Exact Sciences (Genomic Health)
• Biocept
• Biocartis
• Roche Diagnostics
• Myriad Genetics Inc.
• Qiagen
• NeoGenomics Laboratories
• Quest Diagnostics Inc.

Europe Biopsy Devices Market
12
Europe Biopsy Devices Market
Europe Biopsy Devices Market
13
Europe Biopsy Devices Market
Europe Biopsy Devices Market
14
Contact Us
Europe Biopsy Devices Market